You searched for "treatment"
BUS for urethral stricture
The earliest description of urethral stricture and its treatment occurred in the sixth century BC in India. A wide variety of factors can lead to stricture disease e.g. iatrogenic, urinary tract infection (UTI), sexually transmitted infections, catheters, trauma to the...Minze Uroflow System
Minze Uroflow System with Bluetooth makes it possible for men, women and children with LUTs and bladder dysfunction to be assessed, diagnosed and monitored remotely in the comfort of their homes.MAPLe – the pelvic floor in high definition. One probe, all dysfunctions
The MAPLe high-definition technology enables you to diagnose and view a patient’s individual pelvic floor muscle EMG activity at a glance, making it possible for you to provide a more...Prostate Cancer: 'A Marathon, Not a Sprint' Podcast
Men Only was established to offer a platform for men to openly discuss issues important to them. This platform provides a safe space for open dialogue and exploration of topics that are frequently marginalised in mainstream conversations. The platform aims...Action Bladder Cancer UK to open applications for bladder cancer research grants
Action Bladder Cancer UK (ABC UK) will open applications in November 2024 for its 2026 research funding programmes, supporting projects that improve the care, treatment, or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for...Action Bladder Cancer UK offering grants for bladder cancer research
Action Bladder Cancer UK (ABC UK) is inviting applications for its 2026 research funding programmes, supporting projects that improve the care, treatment or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for Patients Programme (IOPP)...
PARP inhibitors and prostate cancer
The discovery that BRCA1/2-deficient tumour cells are highly sensitive to poly-ADP ribose polymerase (PARP) inhibitors (PARPi) established the foundation of synthetic lethality in metastatic castration-resistant prostate cancer (mCRPC). The TOPARP-A trial confirmed clinical benefit, with PARPi activity largely restricted to...
Upper pole access is safe and effective for paediatric percutaneous nephrolithotomy
Upper pole access for percutaneous nephrolithotomy (PCNL) provides a straight access tract to the ureter with easier placement of a guidewire, good exposure of the pelvis and upper ureter, and comfortable manipulations for the treatment of staghorn, large upper caliceal,...
BCG strain differences have an impact on clinical outcome in bladder cancer immunotherapy
Bacillus Calmette-Guérin (BCG) has been part of the treatment algorithm for non-muscle invasive bladder cancer (NMIBC) for a number of years. In this single centre, prospective, randomised trial, two of the most commonly available strains, BCG Connaught and BCG Tice,...RSM: Key Issues in Endourology
Join the Royal Society of Medicine (RSM) Urology Section for this annual meeting exploring key issues in endourology. Bringing together leading clinicians and innovators, the programme will examine the latest developments in stone disease management, benign prostatic enlargement and the technologies shaping contemporary endourological practice.
